Tumor-Inhibiting Protein Could Be Effective In Treating Leukemia

 16.07.2008 10:15   medicalnewstoday.com

Angiocidin, a tumor-inhibiting novel protein discovered by Temple University researchers, may also have a role as a new therapeutic application in treating leukemia, according to a study by the researchers. The study, "The Novel Angiogenic Inhibitor, Angiocidin, Induces Differentiation of Monocytes to Macropahges," was published in the July 15 issue of the journal Cancer Research (

World Biology